Are you Dr. Goldfarb?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1215 Lee St
Charlottesville, VA 22908Phone+1 888-882-3990Fax+1 434-243-6499
Summary
- Dr. Adam Goldfarb, MD is a board certified pathologist in Charlottesville, Virginia. He is currently licensed to practice medicine in Virginia, Ohio, and Minnesota. He is affiliated with University of Virginia Medical Center and is a Professor of Pathology at University VA School of Medicine.
Education & Training
- University of MinnesotaResidency, Pathology-Anatomic and Clinical, 1986 - 1993
- University of MinnesotaFellowship, Hematopathology, 1988 - 1989
- Tufts University School of MedicineClass of 1986, MD
Certifications & Licensure
- VA State Medical License 1998 - 2026
- OH State Medical License 1993 - 1998
- MN State Medical License 1987 - 1993
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- Chromatin structure and 3D architecture define the differential functions of PU.1 regulatory elements in blood cell lineages.Kevin Qiu, Duc C Vu, Leran Wang, Nicholas N Nguyen, Anna K Bookstaver
Epigenetics & Chromatin. 2024-11-01 - Transcriptional Regulation of the Lineage-Determining Genein Normal and Malignant Hematopoiesis: Current Understanding and Therapeutic Perspective.Emilia A Korczmar, Anna K Bookstaver, Ellison Ober, Adam N Goldfarb, Daniel G Tenen
Frontiers in Bioscience. 2024-05-06 - 5 citationsNormal and dysregulated crosstalk between iron metabolism and erythropoiesis.Yelena Ginzburg, Xiuli An, Stefano Rivella, Adam Goldfarb
Elife. 2023-08-14
Press Mentions
- UVA Research May Improve Treatment of AnemiaApril 27th, 2021
Grant Support
- Preclinical Development Of A New Drug For Treating Anemia Of Chronic InflammationNational Institute On Aging2012
- Characterization Of A Novel Erythropoietin Signaling PathwayNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Iron Deficiency: Molecular And Cellular ConsequencesNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Involvement Of RUNX1 In Megakaryocytic DifferentiationNational Cancer Institute2008
- Involvement Of RUNX1 In Megakaryocytic DifferentiationNational Cancer Institute2003–2007
- Regulatory Pathways In Megakaryocyte DifferentiationNational Cancer Institute2002–2006
- Detailed Analysis Of Scl/Tal Dimerization With E ProteinNational Cancer Institute1998–2001
- Detailed Analysis Of Scl/Tal Dimerization With E ProteinNational Cancer Institute1997–1998